Lord, Abbett & Co. LLC Abb Vie Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.7 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,634,739 shares of ABBV stock, worth $297 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
1,634,739
Previous 1,777,221 8.02%
Holding current value
$297 Million
Previous $305 Million 5.9%
% of portfolio
1.05%
Previous 1.0%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$163.84 - $199.33 $23.3 Million - $28.4 Million
-142,482 Reduced 8.02%
1,634,739 $323 Million
Q2 2024

Oct 07, 2024
BUY
$154.79 - $180.76 $4.03 Million - $4.7 Million
26,012 Added 1.49%
1,777,221 $305 Million
Q2 2024

Aug 14, 2024
BUY
$154.79 - $180.76 $4.03 Million - $4.7 Million
26,012 Added 1.49%
1,777,221 $305 Million
Q1 2024

Oct 07, 2024
SELL
$159.82 - $182.1 $4.02 Million - $4.58 Million
-25,171 Reduced 1.42%
1,751,209 $319 Million
Q1 2024

May 09, 2024
SELL
$159.82 - $182.1 $4.02 Million - $4.58 Million
-25,171 Reduced 1.42%
1,751,209 $319 Million
Q4 2023

Oct 07, 2024
SELL
$137.6 - $154.97 $28.1 Million - $31.6 Million
-203,968 Reduced 10.3%
1,776,380 $275 Million
Q4 2023

Feb 12, 2024
SELL
$137.6 - $154.97 $28.1 Million - $31.6 Million
-203,968 Reduced 10.3%
1,776,380 $275 Million
Q3 2023

Oct 07, 2024
SELL
$133.59 - $154.65 $12.3 Million - $14.3 Million
-92,439 Reduced 4.46%
1,980,348 $295 Million
Q3 2023

Nov 13, 2023
SELL
$133.59 - $154.65 $12.3 Million - $14.3 Million
-92,439 Reduced 4.46%
1,980,348 $295 Million
Q2 2023

Oct 07, 2024
BUY
$132.51 - $164.9 $170,407 - $212,061
1,286 Added 0.06%
2,072,787 $279 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $170,407 - $212,061
1,286 Added 0.06%
2,072,787 $279 Million
Q1 2023

Oct 07, 2024
SELL
$144.61 - $166.54 $8.5 Million - $9.79 Million
-58,795 Reduced 2.76%
2,071,501 $330 Million
Q1 2023

May 12, 2023
SELL
$144.61 - $166.54 $8.5 Million - $9.79 Million
-58,795 Reduced 2.76%
2,071,501 $330 Million
Q4 2022

Oct 07, 2024
BUY
$138.31 - $165.87 $48.8 Million - $58.6 Million
353,075 Added 19.87%
2,130,296 $344 Million
Q4 2022

Feb 10, 2023
SELL
$138.31 - $165.87 $6.01 Million - $7.21 Million
-43,456 Reduced 2.0%
2,130,296 $344 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $9.71 Million - $11.1 Million
-72,358 Reduced 3.22%
2,173,752 $292 Million
Q2 2022

Aug 12, 2022
SELL
$137.62 - $174.96 $64.2 Million - $81.7 Million
-466,822 Reduced 17.21%
2,246,110 $344 Million
Q1 2022

May 13, 2022
BUY
$131.98 - $163.75 $1.76 Million - $2.19 Million
13,365 Added 0.5%
2,712,932 $440 Million
Q4 2021

Feb 11, 2022
BUY
$107.43 - $135.93 $19.2 Million - $24.3 Million
178,734 Added 7.09%
2,699,567 $366 Million
Q3 2021

Nov 09, 2021
BUY
$106.4 - $120.78 $58.6 Million - $66.5 Million
550,459 Added 27.94%
2,520,833 $272 Million
Q2 2021

Aug 11, 2021
SELL
$105.21 - $117.21 $14.3 Million - $16 Million
-136,220 Reduced 6.47%
1,970,374 $222 Million
Q1 2021

May 11, 2021
BUY
$102.3 - $112.62 $7.84 Million - $8.63 Million
76,631 Added 3.77%
2,106,594 $228 Million
Q4 2020

Feb 09, 2021
BUY
$80.49 - $108.67 $14.2 Million - $19.2 Million
176,949 Added 9.55%
2,029,963 $218 Million
Q3 2020

Nov 12, 2020
BUY
$85.91 - $100.83 $27.7 Million - $32.5 Million
322,249 Added 21.05%
1,853,014 $162 Million
Q2 2020

Aug 14, 2020
BUY
$73.37 - $98.18 $24 Million - $32.1 Million
327,450 Added 27.21%
1,530,765 $150 Million
Q1 2020

May 14, 2020
BUY
$64.5 - $97.79 $4.91 Million - $7.44 Million
76,060 Added 6.75%
1,203,315 $91.7 Million
Q4 2019

Feb 14, 2020
BUY
$72.13 - $90.25 $58.7 Million - $73.4 Million
813,549 Added 259.33%
1,127,255 $99.8 Million
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $736,866 - $885,924
-11,700 Reduced 3.6%
313,706 $23.8 Million
Q2 2019

Aug 14, 2019
SELL
$65.7 - $83.98 $65,700 - $83,980
-1,000 Reduced 0.31%
325,406 $23.7 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $9.95 Million - $11.7 Million
-129,000 Reduced 28.33%
326,406 $26.3 Million
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $1.07 Million - $1.32 Million
-13,800 Reduced 2.94%
455,406 $42 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $17 Million - $18.9 Million
-191,200 Reduced 28.95%
469,206 $44.4 Million
Q2 2018

Aug 14, 2018
SELL
$89.78 - $106.23 $76.9 Million - $91 Million
-856,775 Reduced 56.47%
660,406 $61.2 Million
Q1 2018

May 15, 2018
SELL
$92.01 - $123.21 $20.4 Million - $27.3 Million
-221,925 Reduced 12.76%
1,517,181 $144 Million
Q4 2017

Feb 14, 2018
SELL
$89.56 - $98.21 $5.14 Million - $5.64 Million
-57,400 Reduced 3.2%
1,739,106 $168 Million
Q3 2017

Nov 14, 2017
BUY
$69.85 - $89.22 $10.9 Million - $13.9 Million
155,488 Added 9.48%
1,796,506 $160 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,641,018
1,641,018 $119 Million

Others Institutions Holding ABBV

# of Institutions
3,849
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $321B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email